Leap therapeutics reports second quarter 2023 financial results

Cambridge, mass. , aug, 14, 2023 /prnewswire/ -- leap therapeutics, inc. (nasdaq:lptx), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for second quarter ended june 30, 2023.

LPTX Ratings Summary

LPTX Quant Ranking